Russell Kent Pachynski, MD is a Hematology / Oncology Specialist - Oncologist (Cancer) practicing in Saint Louis, MO
He has not yet shared a personalized biography with Doctor.com.
University | Degree | Focus | Graduated |
---|---|---|---|
University Of Ws School of Medicine-Madison | Medical Degree | 2003 |
Institution | Focus | Year |
---|---|---|
Residency - Stanford University - CAPS | 2005 | |
Fellowship - Stanford University - CAPS | 2009 |
Certification | Cert. Body | Year |
---|---|---|
Internal medicine | Internal Medicine | Not Specified |
Internal medicine | Internal Medicine | 2007 |
Publication | Publisher | Title | Published |
---|---|---|---|
Other Publication | JOURL OF EXPERIMENTAL MEDICINE | The chemoattractant chemerin suppresses melanoma by recruiting tural killer cell antitumor defenses | 2012 |
Other Publication | BLOOD | Extranodal dissemition of non-Hodgkin lymphoma requires CD47 | 2011 |
Other Publication | Jourl of Clinical Oncology, 2007 ASCO Annual Meeting Proceedings | Prostate specific antigen doubling time | 2007 |
Other Publication | JOURL OF IMMUNOLOGY | Secondary lymphoid-tissue chemokine (SLC) stimulates integrin alpha(4)beta(7) | 1998 |
Other Publication | JOURL OF CELL BIOLOGY | Presentation of integrins on leukocyte microvilli | 1997 |
Other Publication | JOURL OF IMMUNOLOGY | Structure-function alysis of the integrin beta | 1997 |
Other Publication | JOURNAL OF EXPERIMENTAL MEDICINE | The chemoattractant chemerin suppresses melanoma by recruiting natural killer cell antitumor | 2012 |
Other Publication | IMMUNITY | Plasmacytoid Dendritic Cells Transport Peripheral Antigens to the Thymus to Promote Central | 2012 |
Other Publication | BLOOD | Extranodal dissemination of non-Hodgkin lymphoma requires CD47 | 2011 |
Other Publication | BLOOD | CD137 stimulation enhances the antilymphoma activity of anti-CD20 antibodies | 2011 |
Other Publication | Journal of Clinical Oncology, 2007 ASCO Annual Meeting Proceedings | Prostate specific antigen doubling time | 2007 |
Other Publication | HUMAN GENE THERAPY | Redirecting migration of T cells to chemokine secreted from tumors by genetic modification with | 2002 |
Other Publication | JOURNAL OF IMMUNOLOGY | Secondary lymphoid-tissue chemokine (SLC) stimulates integrin alpha(4)beta(7) | 1998 |
Other Publication | JOURNAL OF CELL BIOLOGY | Presentation of integrins on leukocyte microvilli | 1997 |
Other Publication | JOURNAL OF IMMUNOLOGY | Structure-function analysis of the integrin beta | 1997 |
Russell Kent Pachynski, MD has not yet indicated the hospitals that he is affiliated with.
Years In Practice: 15 (started in 2010)
Accepts New Patients: Yes
Russell Kent Pachynski, MD has not yet listed the medications that he commonly prescribes.
Russell Kent Pachynski, MD has not yet added any information about his practice's billing policies and payment options.